Skip to content
Home
Who We Are
About Us
Team
Advisory Board
Partners
What We Do
AMR Diagnostics
AMRx®
AMR Therapeutics
AMR Lab
How We Work
Drug Discovery Platforms
AMRx® De novo
AMRx® Drug Repurposing
Patents
Blog
Contact us
Home
Who We Are
About Us
Team
Advisory Board
Partners
What We Do
AMR Diagnostics
AMRx®
AMR Therapeutics
AMR Lab
How We Work
Drug Discovery Platforms
AMRx® De novo
AMRx® Drug Repurposing
Patents
Blog
Contact us
February 23, 2026
SCIINV Develops first AI-driven anti-microbial candidate
Prev
Previous
Received an honorary medal from the European Exhibition of Creativity and Innovation (EECI), IASI, Romania Chapter, in recognition of exemplary contributions to the medical domain and significant impact on human health through the development of the AMRx®️ solution, at the 23rd International Exhibition of Inventions (ARCA 2025), held in Zagreb, Croatia, from 16th to 18th October 2025.
Next
Hyderabad-based startup to begin human clinical trials for India’s first AI-driven antibiotic
Next
